Preclinical evaluation of M-DGN549, a folate receptor alpha-targeting antibody–drug conjugate (ADC) with a DNA-alkylating payload. (December 2016) - Setiady, Y.; Lanieri, L.; Ab, O.; Maloney, E.; Hong, E.; Qiu, Q.; Zhou, Y.; Zhao, J.; Themeles, M.; Zhang, X.; Pinkas, J.; Ruiz Soto, R.; et al.